Source link : https://newshealth.biz/health-news/niraparib-shows-mixed-signals-in-early-prostate-cancer-treatment/
(MedPage Today) — At the recent American Urological Association annual meeting, data on niraparib (Zejula) in treatment-naive, DNA damage repair (DDR)-deficient localized prostate cancer offered new insights — but also raised important questions… Source link : https://www.medpagetoday.com/meetingcoverage/auavideopearls/115745 Author : Publish date : 2025-05-23 16:23:00 Copyright for syndicated content belongs to the linked Source.
The post Niraparib Shows Mixed Signals in Early Prostate Cancer Treatment first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-23 16:23:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8